Navigation Links
Ischemic in Medical Technology

CoAxia, Inc. Announces $21.5M Series D Financing

... trial of NeuroFlo(TM) technology for acute ischemic stroke. The company has now enrolled over 75% of ... treatment, and thus treat more than 500,000 ischemic stroke patients per year - resulting in a market ... been interested in treatment opportunities in ischemic stroke, given the very large, global, untreated ...

Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers

... products and devices for cardiovascular, ischemic and related indications. Cardium's InnerCool ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ... circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more ...

D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients

... Phase III clinical trial of DP-b99 in acute ischemic stroke patients. D-Pharm plans to initiate ... It is designed to compare the effect on ischemic stroke outcome between a placebo group and a ... plans to enroll 770 moderate to severely affected ischemic stroke patients in over 100 clinical sites in ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... factor-1 alpha ligand that is expressed in ischemic heart tissue following a heart attack. This ... products and devices for cardiovascular, ischemic and related indications. Cardium's InnerCool ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ...

Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms

... 79 should use aspirin to reduce their risk for ischemic stroke when the benefits outweigh the harms for potential gastrointestinal bleeding. ischemic strokes occur as a result of an obstruction ... less likely to occur in men younger than 45 and ischemic strokes are less likely to occur in women younger ...

Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology

... products and devices for cardiovascular, ischemic and related indications. Cardium's InnerCool ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ... circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more ...

Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009

... Inc., transcranial laser therapy (TLT) for acute ischemic stroke within 24 hours of stroke onset ... as it may expand the treatment window for ischemic stroke to 24 hours. We look forward to ... the NEST-3 Steering Committee. About Acute ischemic Stroke According to the American Stroke ...

Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis

... of Viprinex(TM) for the treatment of acute ischemic stroke are unlikely to show benefit. As a result, ... patients' outcome 90 days following an acute ischemic stroke, comparing treatment with Viprinex to ... for evaluation as a new drug to treat acute ischemic stroke; the future development of Viprinex is ...

Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data

... (ancrod) Phase 3 clinical program for acute ischemic stroke, the company plans to consolidate and ... and safety of Viprinex for the treatment of acute ischemic stroke when initiated within six hours of stroke ... investigational drug for the treatment of acute ischemic stroke. Viprinex has multiple mechanisms of ...

ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin

... The MITI IV (Microplasmin In Treatment of ischemic stroke - IntraVenous) trial was a Phase II, ... patients, 4 to 12 hours after onset of acute ischemic stroke. The trial investigated three dose ... brain edema and hemorrhagic transformation after ischemic stroke. Professor Vincent Thijs, Lead Principal ...

Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials

... reduce disability following an acute ischemic stroke. The trials are being conducted in 14 ... investigational drug for the treatment of acute ischemic stroke. Viprinex has multiple mechanisms of ... regarding the development of Viprinex for acute ischemic stroke, delays or other problems with our ...

Concentric Medical to Sponsor Randomized Trial

... the global leader in devices for clot removal in ischemic stroke patients, today announced its plan to ... trial of Endovascular TReatment of acute ischemic strokE Versus mEdical management). The trial, ... and removing blood clots that cause ischemic stroke. The Merci Retrieval System is available ...

Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa

... effects of Epoetin alfa in patients with acute ischemic stroke. In this study, patients suffering acute ischemic stroke who were treated with Epoetin alfa within ... in any country for use in patients with acute ischemic stroke. Epoetin alfa is a member of the class of ...

Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials

... Viprinex(TM) (ancrod) for the treatment of acute ischemic stroke has reached the level of ... Viprinex is safe and effective for treating acute ischemic stroke when given within six hours of stroke ... to learning the outcome of this review." About ischemic Stroke ...

Cardium Reports on Second Quarter 2008 Highlights and Financial Results

... products and devices for cardiovascular, ischemic and related indications. Cardium's lead product ... circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ...

Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities

... products and devices for cardiovascular, ischemic and related indications. Cardium's lead product ... circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ...

Novel Approach May Protect Against Heart Attack Injury

... who showed that HDAC inhibitors reduce ischemic injury in the brain, they used the same agents in ... injury, even when delivered an hour after the ischemic event occurred." The size of the ... HDAC inhibitors work in protecting against ischemic injury in larger animals. A National Institutes ...

PRoFESS(R) Results Announced at XVII European Stroke Conference

... clopidogrel (0.8% and 0.4%, respectively) while ischemic stroke recurrences were less frequent in the ... of people who survive a first stroke or transient ischemic attack (TIA or "mini stroke"), will experience ... had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX is the only ...

Fifth DSMB Meeting Supports Neurobiological Technologies' Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)

... Treatment Within 6 Hours of the Onset of Acute, ischemic Stroke. -- ASP-II- A Randomized, Double-Blind, ... within 6 Hours of the Onset of Acute, ischemic Stroke. About Neurobiological Technologies: ... to expand the treatment window for treating acute ischemic stroke, one of the most prevalent, debilitating ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... a rapidly-advancing field focused on preserving ischemic tissue and improving patient outcomes following ... order to reduce cell death and damage caused by ischemic events in which blood flow to critical ... (such as the heart, brain, and kidneys) following ischemic or inflammatory events, by lowering metabolism ...

CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors

... Perfusion Augmentation Therapy for ischemic Stroke MINNEAPOLIS, April 1, 2008 /PRNewswire/ ... Perfusion Augmentation Therapy in acute ischemic stroke, as well as other ongoing feasibility ... has the potential to be widely applied in ischemic stroke -- with major benefit to stroke ...

Cardium and Tissue Repair Company's Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.

... products and devices for cardiovascular, ischemic and related indications. Cardium's lead product ... circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more ... to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to ...

Multi Merci Trial Results Published in Peer Reviewed Journal

... the global leader in devices for clot removal in ischemic stroke patients, today announced that the results ... capturing and removing blood clots that cause ischemic stroke. The full, peer reviewed trial results are ... in any other device trial in large vessel acute ischemic stroke patients. Ninety-day clinical outcomes in ...

ImaRx Therapeutics Transitions Business Strategy

... proprietary microbubbles and ultrasound to treat ischemic stroke. This shift of business strategy to ... its SonoLysis program for the treatment of ischemic stroke while monetizing its existing inventory of ... with tPA in patients suffering from acute ischemic stroke. According to Andrei Alexandrov, MD, ...

Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood

... and/or ischemic lesions, and 18 percent had ischemic lesions only. Low Performance IQ and Processing Speed Index were significantly associated with ischemic lesions. Adjusting for age and gender, ... lower hemoglobin scores had lower IQ scores, and ischemic lesions alone did not account for the extent of ...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

... in Secondary Prevention of Atherothrombotic ischemic Events (TRA 2P-TIMI 50) trial is a ... in ACS patients and in patients with previous ischemic events that further documented the lack of ... (ACS), such as myocardial infarction (MI), and ischemic stroke, which are the leading causes of death. ...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

... thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, ... macular edema, retinal hemorrhage, cotton wool spots, papilledema, ischemic and hemorrhagic cerebrovascular events, bone marrow toxicity (cytopenia ...

Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients

... thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, ... macular edema, retinal hemorrhage, cotton wool spots, papilledema, ischemic and hemorrhagic cerebrovascular events, bone marrow toxicity (cytopenia ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic ischemic Events (TRA 2P-TIMI 50) trial is a multinational, randomized, ... acute coronary syndromes (ACS), such as myocardial infarction (MI), and ischemic stroke, which are the leading causes of death. Platelets are activated at ...

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

... thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, ... macular edema, retinal hemorrhage, cotton wool spots, papilledema, ischemic and hemorrhagic cerebrovascular events, bone marrow toxicity (cytopenia ...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... targeted by the Company with research programs currently underway include: ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and ... Hopkins University researchers, and also reversed paralysis in rats with ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in ...

Neuralstem's ALS Trial on Clinical Hold

... targeted by the Company with research programs currently underway include: ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and ... Hopkins University researchers, and also reversed paralysis in rats with ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in ...

Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research

... strokes, by opening up blocked arteries in the brain. Treatments for ischemic stroke currently include delivering clot-busting drugs to the blockage ... they're caused by a blocked blood vessel. About 700,000 people suffer an ischemic stroke every year. The remaining 15 percent of strokes are hemorrhagic and ...

Portable CT Increases Chance of Stroke Survival and Recovery

... cases of stroke are diagnosed annually. The most common kind of stroke, ischemic stroke, occurs when a blood clot blocks a blood vessel in the brain. Such ... clotting. "tPA is usually the only shot we have at clot-induced ischemic strokes," Dr. Weinreb said. "But it needs to be administered in a closely ...

Do You Know You're Having a Stroke?

... who were diagnosed at Mayo Clinic's emergency department with either acute ischemic stroke or a transient ischemic attack (TIA), a temporary interruption of blood flow to part of the brain. ...

Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology

... targeted by the Company with research programs currently underway include: ischemic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have ... Hopkins University researchers, and also reversed paralysis in rats with ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in ...

Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property

... RGC death in vivo, the hallmarks of glaucoma and acute injuries such as ischemic optic neuropathy. Dr. Daniel Zurr, Quark's Chief Executive Officer, ... for retinal ganglion cells in acute injuries such as non-artheritic ischemic optic neuropathy, and also in slow-progressing chronic optic nerve ...

Neuralstem Announces Issuance of Core Technology Patent in Europe

... targeted by the Company with research programs currently underway include: ischemic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have ... Hopkins University researchers, and also reversed paralysis in rats with ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in ...

Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation

... transport. The time during transport in this method is referred to as cold ischemic time, more specifically the interval beginning when an organ is removed ... a living, beating state. Preserving an organ with this method reduces cold ischemic time and allows for evaluation of organ function during transport. About ...

ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke

... to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke. The trial design includes four dose cohorts of 18 subjects each ... therapy employs a fundamentally unique approach to the treatment of ischemic stroke. I am excited about the opportunity to participate in future ...
Other Contents
(Date:8/1/2014)... cell research will provide enormous opportunities for both ... could replicate any other cells in the body, ... damaged spinal cords, treating kidney, liver and lung ... for profit is staggering. Prof. Jinhui Chen from ... of research still faces myriad biological, ethical, legal, ...
(Date:8/1/2014)... may soon have a more effective way to control ... researchers from the National University of Singapore (NUS). , ... the Department of Pharmacology at the NUS Yong Loo ... Wanxing, a recent PhD graduate from the Saw Swee ... artesunate, a common herbal-based anti-malarial drug, can be used ...
(Date:7/31/2014)... AMHERST, Mass. A first-of-its-kind study of bigeye tuna ... Lutcavage, director of the Large Pelagics Research Center at ... that these fish cover a wide geographical range with ... shelf, and they favor a high-use area off Cape ... research, which used a new approach to study one ...
Breaking Biology News(10 mins):NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2Study of bigeye tuna in Northwest Atlantic uses new tracking methods 2Study of bigeye tuna in Northwest Atlantic uses new tracking methods 3
(Date:8/1/2014)... New York (PRWEB) August 01, 2014 ... in the wake of the 2012 Rejuvenate and ... move forward in New Jersey’s Bergen County Superior ... filed in the proceeding, the Court has ... Confidentiality governing any and all hard copy and ...
(Date:8/1/2014)... Almost 140 people die every year in accidents ... But there are several simple ways to ... coordinator at Cincinnati Children,s Hospital Medical Center,s Comprehensive ... news release. "As families begin to prepare ... parents and children to go over school bus ...
(Date:8/1/2014)... 01, 2014 As it continues to ... women who allegedly experienced the spread of uterine cancers ... surgeries, Bernstein Liebhard LLP notes the growing reaction to ... power morcellators marketed by its Ethicon, Inc. unit from ... York Times, some critics of the company said they ...
(Date:8/1/2014)... 01, 2014 The evolving healthcare ... community pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good ... practices and resources to enhance patient care and ... on critical issues to give independent pharmacists the ... , ThoughtSpot show attendance experienced a nearly ...
(Date:8/1/2014)... gay, bisexual, and transgender individuals who want to conceive ... of their heterosexual and cisgendered peers, such as reduced ... physiological and legal challenges to become parents. A comprehensive ... options is presented in the article " LGBT Assisted ... LGBT Health , a peer-reviewed journal ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Expert Offers School Bus Safety Tips 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:Advances in assisted reproduction create more options and new legal issues for LGBT couples 2
Other TagsOther Tags